The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
Featured Articles
Search
Author Details
Jenifer Propets
Lorem ipsum dolor sit amet, adipiscing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.